Sophie C. McGrath

Described by Chambers as “a superb corporate lawyer,” Sophie McGrath is a partner in Goodwin’s Life Sciences, Healthcare and Technology groups. Sophie has over 20 years’ experience focusing on transactions in the life sciences, healthcare and technology sectors, acting for companies at all stages of development, as well as investors and management teams. She advises on a wide range of corporate matters, including private and public financings, mergers and acquisitions, public offerings, and restructurings.

Sophie is a recommended lawyer for Chambers UK and Legal 500. She is described by Legal 500 as having “unbeatable knowledge and experience, especially in the life sciences and technology industries” and as “one of the best VC lawyers in the market”.

As the Co-Chair of Goodwin’s European Healthcare initiative, Sophie plays a pivotal role in shaping the firm’s strategic initiatives in this sector. Sophie collaborates with Goodwin attorneys across multiple disciplines such as corporate, commercial, intellectual property, private equity and regulatory to ensure that the firm’s European Healthcare clients are receiving cutting edge legal advice on the distinct challenges and opportunities within the European healthcare sector. With a sharp focus on emerging legal trends, Sophie has a particular interest in the growth of private equity investments within the Life Sciences and Healthcare sectors and works closely with her colleagues in the Private Equity team to provide clients with invaluable insights and strategic legal counsel on these transactions.

Sophie is one of the leaders of Goodwin’s Women’s Health and Wellness Initiative and is heavily involved in supporting entrepreneurs, companies and investors dedicated to advancing innovation in the field of women’s health and wellness. Sophie is also passionate about promoting and supporting women in the Life Sciences, Healthcare and Technology sectors, representing an impressive portfolio of women led companies such as Micrographia, Dunad, Aavantgarde and Jeito, the first women led life sciences focused venture capital fund. Sophie leads various initiatives and events at Goodwin focusing on women, including its annual Women in Life Sciences networking event and its Female Founders Dinner.

Sophie was the recipient of the Collaborative Leadership Award at the 2024 Women, Influence & Power in Law (WIPL) UK Awards. Sophie has also been shortlisted as Legal Advisor of the Year at the Women in Finance Awards 2021, 2022, and 2023. 

Sophie is a member of the British Venture Capital Association.

Sophie is an Expert in Residence for Women of Wearables.

• Sophie was the recipient of the Collaborative Leadership Award at the 2024 Women, Influence & Power in Law (WIPL) UK Awards.
• Sophie was recognized as a Leading Individual by Legal 500 UK 2024, 2023 and 2022 for Venture Capital, in which she is described as “one of the best VC lawyers in the market. She has unbeatable knowledge and experience, especially in the life sciences and technology industries.”
• Sophie was recognized by Chambers UK 2024, 2023 and 2022 for her work in Private Equity: Venture Capital Investment. Client testimonials described her as “a superb corporate lawyer. She is always direct, very supportive and helpful" and note she is a “fantastic partner to work with” .
• Sophie has been shortlisted for Legal Adviser of the Year by the Women in Finance Summit & Awards Series 2021, 2022 and 2023.

Sophie’s recent speaking engagements include:

• Author, “FemTech – A market on the rise”, Maddyness 17 May 2022 
• Author, “How is new innovation giving a much-needed boost to women’s health and wellness?”, Maddyness 6 April 2022 
• Quoted, “Investors' Diversity Quest May Push Women's Health Out of the Doldrums,” S&P Global Market Intelligence, 29 March 2022
• Speaker, “Legal Funding 101: Garnering Support for Women's Health,” Women of Wearables Knowledge Hub, 7 July 2021